Canadian Journal of Infectious Diseases and Medical Microbiology · 2007 · 14 citations · 60 references
PharmacyInfectious DiseasesPharmacotherapyInfectious Disease PharmacotherapyMolecular VirologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral TherapyInterferon-based TherapyTreatmentViral HepatitisAntiviral TherapeuticsAntiviral TreatmentCombination Antiviral RegimensHepatitis C InfectionHepatitis C Virus ManagementRibavirin TherapySurvival RatesTreatment In Coinfected Patients
Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective antiretroviral therapies have prolonged survival rates for HIV-infected people over the past decade, which have made latent complications of HCV major causes of morbidity and mortality in these patients. Advances in the treatment of HCV (eg, combined pegylated interferon and ribavirin) offer the possibility of eradicating HCV infection in coinfected persons. The treatment of HCV must be considered in all cases. Intensive management of the adverse effects of HCV treatment is one of the factors for the success of these therapies. HCV eradication is predicted to decrease the mortality associated with coinfection and reduce the toxicity of HIV treatment.
60
Transection of the oesophagus for bleeding oesophageal varices
R. N. H. Pugh, I M Murray-Lyon, J L Dawson et al. · British journal of surgery · 1973 · 8K citations